IBDEI224 ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,934,0)
 ;;=RISK FACTOR REDUCTION^14^80
 ;;^UTILITY(U,$J,358.4,935,0)
 ;;=PREVENTIVE GROUP COUNSELING^11^80
 ;;^UTILITY(U,$J,358.4,936,0)
 ;;=CARDIOVASCULAR^3^81
 ;;^UTILITY(U,$J,358.4,937,0)
 ;;=ENDOCRINE/METABOLIC^7^81
 ;;^UTILITY(U,$J,358.4,938,0)
 ;;=PULMONARY^22^81
 ;;^UTILITY(U,$J,358.4,939,0)
 ;;=EENT^6^81
 ;;^UTILITY(U,$J,358.4,940,0)
 ;;=MUSCULOSKELETAL^17^81
 ;;^UTILITY(U,$J,358.4,941,0)
 ;;=NEURO^18^81
 ;;^UTILITY(U,$J,358.4,942,0)
 ;;=MENTAL HEALTH^16^81
 ;;^UTILITY(U,$J,358.4,943,0)
 ;;=GASTROENTEROLOGY^8^81
 ;;^UTILITY(U,$J,358.4,944,0)
 ;;=GU/RENAL^9^81
 ;;^UTILITY(U,$J,358.4,945,0)
 ;;=WOMEN'S HEALTH^25^81
 ;;^UTILITY(U,$J,358.4,946,0)
 ;;=HEMATOLOGY/ONCOLOGY^10^81
 ;;^UTILITY(U,$J,358.4,947,0)
 ;;=INFECTIOUS DISEASE^12^81
 ;;^UTILITY(U,$J,358.4,948,0)
 ;;=DERMATOLOGY^5^81
 ;;^UTILITY(U,$J,358.4,949,0)
 ;;=HISTORY OF ILLNESS^11^81
 ;;^UTILITY(U,$J,358.4,950,0)
 ;;=INJURY/TRAUMA^13^81
 ;;^UTILITY(U,$J,358.4,951,0)
 ;;=SIGNS, SYMPTOMS, CONDITIONS^24^81
 ;;^UTILITY(U,$J,358.4,952,0)
 ;;=SEXUAL TRAUMA^23^81
 ;;^UTILITY(U,$J,358.4,953,0)
 ;;=PAIN^20^81
 ;;^UTILITY(U,$J,358.4,954,0)
 ;;=OTHER REASONS^19^81
 ;;^UTILITY(U,$J,358.4,955,0)
 ;;=COMMON DIAGNOSES^2^81
 ;;^UTILITY(U,$J,358.4,956,0)
 ;;=PREVENTIVE MEDICINE CODES^21^81
 ;;^UTILITY(U,$J,358.4,957,0)
 ;;=CONTACT W/ HAZARDOUS SUBSTANCES^1^81
 ;;^UTILITY(U,$J,358.4,958,0)
 ;;=CAUSES OF INJURY (SECONDARY ONLY)^4^81
 ;;^UTILITY(U,$J,358.4,959,0)
 ;;=LEGAL BLINDNESS^14^81
 ;;^UTILITY(U,$J,358.4,960,0)
 ;;=BLOODS, ARTERIAL & VENOUS^1^82
 ;;^UTILITY(U,$J,358.4,961,0)
 ;;=OXIMETRY (WHEN ONLY SERVICE)^7^82
 ;;^UTILITY(U,$J,358.4,962,0)
 ;;=PULMONARY FUNCTION TESTING^9^82
 ;;^UTILITY(U,$J,358.4,963,0)
 ;;=THORACENTESIS^11^82
 ;;^UTILITY(U,$J,358.4,964,0)
 ;;=RESPIRATORY THERAPY^10^82
 ;;^UTILITY(U,$J,358.4,965,0)
 ;;=BRONCHOSCOPY^2^82
 ;;^UTILITY(U,$J,358.4,966,0)
 ;;=EXERCISE TESTING^3^82
 ;;^UTILITY(U,$J,358.4,967,0)
 ;;=IMMUNIZATION ADMINISTRATION^4^82
 ;;^UTILITY(U,$J,358.4,968,0)
 ;;=IMMUNIZATIONS^5^82
 ;;^UTILITY(U,$J,358.4,969,0)
 ;;=TRACHEOSTOMY^12^82
 ;;^UTILITY(U,$J,358.4,970,0)
 ;;=PROLONGED SVC W/O PT^8^82
 ;;^UTILITY(U,$J,358.4,971,0)
 ;;=MISCELLANEOUS^6^82
 ;;^UTILITY(U,$J,358.4,972,0)
 ;;=NEW PATIENT^2^83
 ;;^UTILITY(U,$J,358.4,973,0)
 ;;=ESTABLISHED PATIENT^1^83
 ;;^UTILITY(U,$J,358.4,974,0)
 ;;=CONSULTATIONS^3^83
 ;;^UTILITY(U,$J,358.4,975,0)
 ;;=SIGNS & SYMPTOMS^24^84
 ;;^UTILITY(U,$J,358.4,976,0)
 ;;=ENDOCRINE & METABOLIC^6^84
 ;;^UTILITY(U,$J,358.4,977,0)
 ;;=HEMATOLOGIC & LYMPHATIC^10^84
 ;;^UTILITY(U,$J,358.4,978,0)
 ;;=EYES, EARS & NOSE^7^84
 ;;^UTILITY(U,$J,358.4,979,0)
 ;;=VASCULAR^29^84
 ;;^UTILITY(U,$J,358.4,980,0)
 ;;=MUSCULOSKELETAL^14^84
 ;;^UTILITY(U,$J,358.4,981,0)
 ;;=GENITOURINARY & RENAL^9^84
 ;;^UTILITY(U,$J,358.4,982,0)
 ;;=CARDIAC^3^84
 ;;^UTILITY(U,$J,358.4,983,0)
 ;;=INTERSTITIAL LUNG DISEASES^13^84
 ;;^UTILITY(U,$J,358.4,984,0)
 ;;=OCCUPATIONAL^17^84
 ;;^UTILITY(U,$J,358.4,985,0)
 ;;=OTHER^18^84
 ;;^UTILITY(U,$J,358.4,986,0)
 ;;=PLEURAL DISEASE^20^84
 ;;^UTILITY(U,$J,358.4,987,0)
 ;;=INFECTIOUS DISEASES^12^84
 ;;^UTILITY(U,$J,358.4,988,0)
 ;;=NEUROMUSCULAR/SKELETAL^16^84
 ;;^UTILITY(U,$J,358.4,989,0)
 ;;=GASTROINTESTINAL^8^84
 ;;^UTILITY(U,$J,358.4,990,0)
 ;;=HEPATIC & BILIARY^11^84
 ;;^UTILITY(U,$J,358.4,991,0)
 ;;=NEUROLOGIC^15^84
 ;;^UTILITY(U,$J,358.4,992,0)
 ;;=SKIN^26^84
 ;;^UTILITY(U,$J,358.4,993,0)
 ;;=PSYCHIATRIC & BEHAVIORAL^21^84
 ;;^UTILITY(U,$J,358.4,994,0)
 ;;=CANCER^2^84
 ;;^UTILITY(U,$J,358.4,995,0)
 ;;=RADIATION^22^84
 ;;^UTILITY(U,$J,358.4,996,0)
 ;;=SKELETAL^25^84
 ;;
 ;;$END ROU IBDEI224
